Aquestive Therapeutics, Inc. — Director's Dealing 2018

Aug 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-08-15

Reporting Person: Schobel Alexander Mark (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-15	Stock Option (Right to Purchase)	$16.46	A	28043	Acquired	2028-08-15	Common Stock (28043)	Direct
2018-08-15	Restricted Stock Unit	$	A	2636	Acquired		Common Stock (2636)	Direct

Footnotes

F1: The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date.

F2: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3: The restricted stock units vest in 8 equal (or as nearly equal as possible) quarterly installments beginning on September 30, 2018, subject in each case to Mr. Schobel's continuous service with the Issuer from the grant date through the applicable vesting date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date thereof.